NATASHA WILLIAMSON: Open Payments
NPI 1760196208 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 63 payments from 16 companies in 2025. Trend: 2023 $91 · 2024 $584 · 2025 $1,138
Food & beverage: $1,052Education: $86
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $303 |
| Aimmune Therapeutics, Inc. | 12 | $209 |
| Janssen Biotech, Inc. | 8 | $190 |
| Madrigal Pharmaceuticals | 3 | $69 |
| Gilead Sciences, Inc. | 4 | $61 |
| Lilly USA, LLC | 3 | $52 |
| Ardelyx, Inc. | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| PFIZER INC. | 2 | $30 |
Products named: ZENPEP, TREMFYA, ENTYVIO, EOHILIA, REZDIFFRA, OMVOH, IBSRELA, IQIRVO.
Industry payments across IA — which companies pay providers there.
